✦ LIBER ✦

A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects

✍ Scribed by Isabelle Loubinoux; Jérémie Pariente; Kader Boulanouar; Christophe Carel; Claude Manelfe; Olivier Rascol; Pierre Celsis; François Chollet

Book ID: 118769679
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 329 KB
Volume: 15
Category: Article
ISSN: 1053-8119
DOI: 10.1006/nimg.2001.0957

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-dependent enhancement of motor acti

Dose-dependent enhancement of motor activation and motor skills by a single dose of paroxetine, a serotonin reuptake inhibitor. A double-blind, placebo-controlled fMRI study in healthy subjects

✍ Loubinoux, Isabelle; Pariente, Jeremie; Carel, Christophe; Manelfe, Claude; Rasc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Selective serotonin reuptake inhibitor p

Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects

✍ Isabelle Loubinoux; Jérémie Pariente; Olivier Rascol; Pierre Celsis; François Ch 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Human reward system activation is modula

Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study

✍ Birgit Abler; Susanne Erk; Henrik Walter 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 274 KB

Pharmacokinetic and Pharmacodynamic Asse

Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects

✍ A. Marie O'Farrell; Andre van Vliet; Khalid Abou Farha; Julie M. Cherrington; Da 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 898 KB

561 Safety and pharmacokinetics of the n

561 Safety and pharmacokinetics of the now nucleoside polymerase inhibitor, HCV-796: Results of a randomized, double-blind, placebo-controlled, ascending single-dose study in healthy subjects

✍ P. Chandra; D. Raible; L. Moyer; D. Harper; J. Speth; S. Villano; R. Fruncillo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers

✍ Naik, Himanshu; Vakilynejad, Majid; Wu, Jingtao; Viswanathan, Prabhakar; Dote, N 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 220 KB